Company Overview of Baxter BioScience Inc.
Baxter BioScience Inc. manufactures plasma-based and recombinant proteins to treat hemophilia. Its products include plasma-based therapies to manage chronic blood-related conditions; bio surgery products for hemostasis, wound-sealing, and tissue regeneration; vaccines; manual and automated blood and blood-component separation, and collection systems; and albumin therapy fluid volume replacement products. Baxter BioScience Inc. also offers GAMMAGARD LIQUID for primary immune deficiencies; WinRho SDF for immune thrombocytopenic purpura; ARALAST for Alpha-1 Antitrypsin Deficiency; CEPROTIN for protein C deficiency; and ADVATE and FEIBA VH for Hemophilia treatment. The company is based in Westla...
One Verizon Way
Westlake Village, CA 91362
Key Executives for Baxter BioScience Inc.
Global Head of Research & Development and Vice President
Compensation as of Fiscal Year 2014.
Baxter BioScience Inc. Key Developments
Baxter BioScience Inc. Appoints John Orloff as President and Global Head of Research and Development
Jul 10 14
Baxter International Inc. announced the appointment of John Orloff, as vice president and global head of research and development for Baxter BioScience Inc., effective immediately. Dr. Orloff joins Baxter from Merck Serono Pharmaceuticals, where he served as global head of clinical development. Dr. Orloff will be responsible for advancing the late-stage BioScience pipeline, enhancing the current R&D operating model and pursuing additional innovative opportunities for the business. Prior to his tenure at Merck Serono, Dr. Orloff spent approximately 10 years at Novartis, where he served in roles of increasing responsibility including chief medical officer for global development.
Baxter BioScience Inc. Presents at BIO International Convention, Jun-24-2014 11:15 AM
Jun 17 14
Baxter BioScience Inc. Presents at BIO International Convention, Jun-24-2014 11:15 AM. Venue: San Diego Convention Center, San Diego, California, United States.
Baxter BioScience Inc. Presents at 2012 Globalization of Innovation: China, India, and US Pharma Markets Symposium, Oct-03-2012 03:30 PM
Oct 1 12
Baxter BioScience Inc. Presents at 2012 Globalization of Innovation: China, India, and US Pharma Markets Symposium, Oct-03-2012 03:30 PM. Venue: 200 E. Randolph St. (Suite 200), Chicago, IL 60601, United States. Speakers: Ashish Sagrolikar, VP, Sales & Marketing.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|